Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Author response to commentary on article "Intensive care unit-acquired infections: It is not only about the number of patients per room".

Sadatsafavi H, Sadatsafavi M.

J Crit Care. 2016 Aug;34:124. doi: 10.1016/j.jcrc.2016.04.026. Epub 2016 Apr 30. No abstract available.

PMID:
27288624
2.

Influences of Socioeconomic Status on Costs of Asthma Under Universal Health Coverage.

Chen W, Lynd LD, FitzGerald JM, Sadatsafavi M.

Med Care. 2016 May 20. [Epub ahead of print]

PMID:
27213543
3.

The asthma control in daily practice.

Ciprandi G, Tosca MA, Cirillo I, Gallo F, Ricciardolo FL, Sadatsafavi M, Mark FitzGerald J.

Allergy. 2016 Jun;71(6):907-9. doi: 10.1111/all.12893. No abstract available.

PMID:
27168014
4.

Less chaos in the prognosis of asthma-chronic obstructive lung disease overlap.

FitzGerald JM, Sadatsafavi M.

Lancet Respir Med. 2016 Jun;4(6):421-2. doi: 10.1016/S2213-2600(16)30036-4. Epub 2016 Apr 6. No abstract available.

PMID:
27061879
5.

Progression from Asthma to Chronic Obstructive Pulmonary Disease (COPD): Is Air Pollution a Risk Factor?

To T, Zhu J, Larsen K, Simatovic J, Feldman L, Ryckman K, Gershon A, Lougheed MD, Licskai C, Chen H, Villeneuve PJ, Crighton E, Su Y, Sadatsafavi M, Williams D, Carlsten C; Canadian Respiratory Research Network.

Am J Respir Crit Care Med. 2016 Mar 7. [Epub ahead of print]

PMID:
26950751
6.

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma.

Zafari Z, Sadatsafavi M, Marra CA, Chen W, FitzGerald JM.

PLoS One. 2016 Jan 11;11(1):e0146003. doi: 10.1371/journal.pone.0146003. eCollection 2016.

7.

The natural history of severe asthma and influences of early risk factors: a population-based cohort study.

Chen W, Marra CA, Lynd LD, FitzGerald JM, Zafari Z, Sadatsafavi M.

Thorax. 2016 Mar;71(3):267-75. doi: 10.1136/thoraxjnl-2015-207530. Epub 2016 Jan 5.

PMID:
26732738
8.

The global economic burden of asthma and chronic obstructive pulmonary disease.

Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M.

Int J Tuberc Lung Dis. 2016 Jan;20(1):11-23. doi: 10.5588/ijtld.15.0472.

PMID:
26688525
9.

Quality of Life and Asthma Symptom Control: Room for Improvement in Care and Measurement.

Sadatsafavi M, McTaggart-Cowan H, Chen W, Mark FitzGerald J; Economic Burden of Asthma (EBA) Study Group.

Value Health. 2015 Dec;18(8):1043-9. doi: 10.1016/j.jval.2015.07.008. Epub 2015 Sep 16.

PMID:
26686789
10.

History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.

Sadatsafavi M, Tavakoli H, Kendzerska T, Gershon A, To T, Aaron SD, FitzGerald JM; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2016 Feb;13(2):188-96. doi: 10.1513/AnnalsATS.201508-507OC.

PMID:
26599154
11.

Do cost savings from reductions in nosocomial infections justify additional costs of single-bed rooms in intensive care units? A simulation case study.

Sadatsafavi H, Niknejad B, Zadeh R, Sadatsafavi M.

J Crit Care. 2016 Feb;31(1):194-200. doi: 10.1016/j.jcrc.2015.10.010. Epub 2015 Oct 20.

PMID:
26586445
12.

Saving in medical costs by achieving guideline-based asthma symptom control: a population-based study.

Sadatsafavi M, Chen W, Tavakoli H, Rolf JD, Rousseau R, FitzGerald JM; Economic Burden of Asthma Study Group.

Allergy. 2016 Mar;71(3):371-7. doi: 10.1111/all.12803. Epub 2015 Dec 9.

PMID:
26529357
13.

The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registry.

Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Mittoo S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M.

Can Respir J. 2015 Nov 2. pii: 17206. [Epub ahead of print] No abstract available.

PMID:
26523546
14.

Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Chen W, Thomas J, Sadatsafavi M, FitzGerald JM.

Lancet Respir Med. 2015 Aug;3(8):631-9. doi: 10.1016/S2213-2600(15)00241-6. Epub 2015 Jul 22. Review.

PMID:
26208998
15.

Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?

Hirota JA, Carlsten C, Sadatsafavi M, Kaplan G, Hirota SA.

Eur Respir J. 2015 Jul;46(1):287-8. doi: 10.1183/09031936.00003815. No abstract available.

PMID:
26130781
16.

Ten-Year Trends in Direct Costs of COPD: A Population-Based Study.

Khakban A, Sin DD, FitzGerald JM, Ng R, Zafari Z, McManus B, Hollander Z, Marra CA, Sadatsafavi M.

Chest. 2015 Sep;148(3):640-6. doi: 10.1378/chest.15-0721.

PMID:
26043120
17.

The added effect of comorbidity on health-related quality of life in patients with asthma.

Chen W, Lynd LD, FitzGerald JM, Marra CA, Rousseau R, Sadatsafavi M.

Qual Life Res. 2015 Oct;24(10):2507-17. doi: 10.1007/s11136-015-0995-6. Epub 2015 Jun 3.

PMID:
26038225
18.

COPD: undefeated!

Sadatsafavi M, Sin DD.

Chest. 2015 Apr;147(4):868-9. doi: 10.1378/chest.14-2979. No abstract available.

PMID:
25846522
19.

Interaction effect of psychological distress and asthma control on productivity loss?

Moullec G, FitzGerald JM, Rousseau R, Chen W, Sadatsafavi M; Economic Burden of Asthma (EBA) study team.

Eur Respir J. 2015 Jun;45(6):1557-65. doi: 10.1183/09031936.00141614. Epub 2015 Feb 5.

PMID:
25657023
20.

One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.

Sadatsafavi M, Lynd LD, De Vera MA, Zafari Z, FitzGerald JM.

Respir Med. 2015 Mar;109(3):320-8. doi: 10.1016/j.rmed.2014.12.014. Epub 2015 Jan 7.

PMID:
25596136
Items per page

Supplemental Content

Loading ...
Write to the Help Desk